China integrates tumor electric field treatment into standard program International cutting-edge innovative therapy for patients with glioblastoma

Qin Zhiyong said that the clinical prognosis of glioblastoma patients is very poor"Surgery plus chemotherapy and tumor electric field therapy" will become a new standard treatment plan.　Chen JingShanghai, June 30 (Reporter Chen Jing) glioblastoma is the most common primary malignant central nervous system tumor, is considered to be one of the most difficult refractive tumors in neurosurgery treatmentSurgery, combined with radiotherapy and chemotherapy, has been a traditional treatment for the diseasereporter s30 learned that Shanghai will be the international cutting-edge innovative therapy - electric field therapy into the glycoblastoma treatment program, benefit inglione cell tumor patientsIn the future, "surgery and chemotherapy and tumor electric field therapy" will become a new standard treatment planMrZhang began to receive cancer electric field treatment on the 30th.　Chen Jingthe same day, launched in Shanghai, a charitable assistance project for patients with glioblastoma, initiated by the China Primary Health Care Foundation, to improve the accessibility of innovative treatment methods, to help more glioblastoma patients reduce the financial burden, and to obtain timely and effective standard treatment earlierHu Ningning, vice president of the China Primary Health Care Foundation of theof the, said he hoped the assistance program would help more patients with glioblastoma to obtain high-quality treatment options in the first place, minimize the financial burden on patients and families, enhance patients' confidence in fighting the disease, and help achieve the goal of increasing the five-year survival rate of the "Healthy China 2030" overall cancer by 15%It is reported that eligible low-insurance and low-income glioblastoma patients can applyProfessor Qin Zhiyong of Neurosurgery of Huashan Hospital affiliated with Fudan University, told reporters on the same day that tumor electric field therapy is a portable, non-invasive new tumor treatment program, the mechanism of which is through low-intensity, medium-frequency AC electric field, acting on the microtube protein of proliferative tumor cells, by interfering with tumor cells have filaments, inhibit tumor growth and cause cancer cells affected by the electric field to dieglioblastoma is highly malignant, fast growth, short course of disease, prone to recurrence after surgery and high disability, the most invasiveQin Zhiyong said that the clinical prognosis of glioblastoma patients is very poor, the median survival period is only 15 months, the recurrence rate is close to 100%, the five-year survival rate of about 5% Qin Zhiyong, of , admitted: "Over the years, the treatment of glioblastoma has been updated very slowly, and the targeted and immunotherapy of high fever in other tumor therapy is still in the exploratory stage of glioblastoma." Only innovative therapy tumor electric field therapy has been proven to be effective and safe in large-scale international clinical trials and has been incorporated into international authoritative guidelines In China, 20 years ago, glioblastoma was incurable, with a life expectancy of only 6-8 months, and now, for example, Huashan Hospital, patients with glioblastoma can expect a median survival time of 16-18 months, said the expert, an expert Tumor electro-field therapy has become a major breakthrough in the treatment of glioblastoma in China in the past 15 years, and it is of epoch-making significance He said that not long ago, the cancer field treatment was approved in China, the future will enter clinical applications, we expect patients to live longer and better Mr Zhang, 48, a , was surgically removed in March and underwent chemotherapy for the next two months On that day, he began to receive cancer electric field treatment Mr Zhang told reporters: "Hopefully this is the beginning of my new life journey!" Source: China News network